ALL-REMOTE COMPANY/WILMINGTON, Del.–(BUSINESS WIRE)–Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the “Company”) announced financial results today for the fiscal second quarter ended July 31, 2026.
“Phreesia delivered a solid fiscal second quarter, with revenue growth and profitability expansion in line with our expectations. We generated positive operating and free cash flow again this quarter, which together with available cash allowed us to reduce debt principal by over $23 million while maintaining a healthy cash balance,” said CEO and Co-Founder Chaim Indig. “We remain enthusiastic about two products that we believe will drive future growth, AccessOne and ProviderConnect, as well as the impact that our artificial intelligence (AI) investments are beginning to have on many aspects of our products and broader organization.”
Please visit the Phreesia investor relations website at ir.phreesia.com to view the Company’s Q2 Fiscal 2027 Stakeholder Letter.
Fiscal Second Quarter Ended July 31, 2026 Highlights
- Total revenue was $129.5 million in the quarter, up 10% year-over-year.
- Average number of healthcare services clients (“AHSCs”) was 4,744 in the quarter, up 6% year-over-year.
- Total revenue per AHSC was $27,289 in the quarter, up 4% year-over-year. See “Key Metrics” below for additional information.
- Net income was $1.9 million in the quarter, as compared to net income of $0.7 million in the same period in the prior year.
- Adjusted EBITDA1 was $32.9 million in the quarter, as compared to $22.1 million in the same period in the prior year.
- Net cash provided by operating activities was $18.3 million in the quarter, as compared to $14.8 million in the same period in the prior year.
- Free cash flow2 was $13.8 million in the quarter, as compared to $9.6 million in the same period in the prior year.
- Cash, cash equivalents and restricted cash as of July 31, 2026 was $74.6 million, an increase of $0.8 million from January 31, 2026. As of July 31, 2026, cash, cash equivalents and restricted cash included $1.7 million of long-term restricted cash classified within other long-term assets.
Recent Developments
Restructuring Plan
On May 7, 2026, we implemented a restructuring plan (the “Plan”) intended to reduce operating expenses and better align the cost structure with our current business priorities. The Plan includes the elimination of approximately 220 positions, approximately half of which are contractor roles. We expect total restructuring charges in connection with the Plan to be approximately $10 million, substantially all of which are expected to consist of employee transition costs, severance payments and related employee benefits, and taxes. Restructuring charges of approximately $2.8 million were recognized for the Plan during the second quarter of fiscal 2027. We expect the Plan to be substantially completed during fiscal year 2027.
Fiscal 2027 Outlook
We are maintaining our revenue outlook for fiscal 2027. We expect revenue to be in the range of $510 million to $520 million. As we noted over the past several quarters, there is now more variability in our network solutions revenue forecasting, particularly in the second half of each fiscal year. Our visibility into revenue across the other parts of our business is generally consistent with our views in our March 2026 earnings disclosure. The revenue range provided for fiscal 2027 assumes approximately $37 million of contribution from AccessOne (as defined below) and no additional revenue from potential future acquisitions completed between now and January 31, 2027.
We are maintaining our Adjusted EBITDA outlook for fiscal 2027. We expect Adjusted EBITDA to be in the range of $125 million to $135 million. As a reminder, in May 2026, we implemented a restructuring plan intended to reduce operating expenses and better align our cost structure with our current business priorities. The plan is expected to result in meaningful annualized run-rate expense savings, which were reflected in our Adjusted EBITDA outlook provided on March 30, 2026 and reaffirmed on May 27, 2026.
We are maintaining our expectation for AHSC growth in the mid-single-digit percentage range, and we are maintaining our outlook for total revenue per AHSC to grow in the low-single-digit percentage range in fiscal 2027.
We believe our cash, cash equivalents, restricted cash and cash generated in our normal operations will be sufficient to reach our fiscal 2027 outlook and meet our obligations for at least the next twelve months. As of July 31, 2026 we had $61 million in borrowings outstanding under our credit facility with Capital One.
Non-GAAP3 Financial Measures
We have not reconciled our Adjusted EBITDA outlook to GAAP net income (loss) because we do not provide an outlook for GAAP net income (loss) due to the uncertainty and potential variability of other expense (income), net and income tax expense (benefit), which are reconciling items between Adjusted EBITDA and GAAP net income (loss). Because we cannot reasonably predict such items, a reconciliation of the non-GAAP financial measure outlook to the corresponding GAAP measure is not available without unreasonable effort. We caution, however, that such items could have a significant impact on the calculation of GAAP net income (loss). For further information regarding the non-GAAP financial measures included in this press release, including a reconciliation of GAAP to non-GAAP financial measures and an explanation of these measures, please see “Non-GAAP Financial Measures” below.
Available Information
We intend to use our Company website (including our Investor Relations website) as well as our Facebook, X, LinkedIn and Instagram accounts as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
Forward-Looking Statements
This press release includes express or implied statements that are not historical facts and are considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or our future financial or operating performance and may contain projections of our future results of operations or of our financial information or state other forward-looking information. These statements include, but are not limited to, statements regarding: our future financial and operating performance, including our revenue, operating leverage, Adjusted EBITDA and cash flows; our expectations regarding demand for our solutions and visibility into future revenue; our expectations regarding our restructuring plan, including the anticipated amount, timing and composition of restructuring charges, reductions in operating expenses and resulting expense savings; the expected results of the acquisition of AccessOne Parent Holdings, Inc. and its subsidiaries (collectively, “AccessOne” and such acquisition, the “AccessOne Acquisition”) discussed herein, including anticipated additional revenue; our ability to meet our obligations for the next twelve months and achieve our fiscal 2027 outlook with our current cash, cash equivalents, restricted cash and cash generated in our normal operations; our outlook for fiscal 2027, including our expectations regarding revenue, Adjusted EBITDA, AHSCs and total revenue per AHSC; our ability to continue generating positive net income and free cash flow; our business strategy and operating plans; the factors that drive our revenue growth; our growth expectations and strategies for the AccessOne business and ProviderConnect; our ability to offer the AccessOne solution to additional clients and access to capital; our expectations regarding new solutions and solutions under development and the use of artificial intelligence in our solutions; and our expectations regarding the impacts of AI across our products and broader organization. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future operational or financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond our control, including, without limitation, risks associated with: our ability to effectively manage our growth and meet our growth objectives; our focus on the long-term and our investments in growth; the ability to integrate operations or realize any operational or corporate synergies and other benefits from the AccessOne Acquisition; the competitive environment in which we operate; our ability to comply with the covenants in our credit facility with Capital One and the securitization program with PNC Bank; changes in market conditions and receptivity to our products and services; our ability to develop and release new products and services and successful enhancements, features and modifications to our existing products and services; our ability to maintain the security and availability of our platform; the impact of cyberattacks, security incidents or breaches impacting our business; changes in laws and regulations applicable to our business model; our ability to make accurate predictions about our industry and addressable market; our ability to attract, retain and cross-sell to healthcare services clients; our ability to continue to operate effectively with a primarily remote workforce and attract and retain key talent; our ability to realize the intended benefits of our acquisitions and partnerships; difficulties in integrating our acquisitions and investments; artificial intelligence that can impact our business, including by posing security risks to our confidential information, proprietary information and personal data, increasing our regulatory and compliance burden and increasing competition; and other general, market, political, economic and business conditions (including from the U.S. federal government, tariff and trade issues, and the warfare and/or political and economic instability in Ukraine, the Middle East or elsewhere). The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those listed or described in our filings with the Securities and Exchange Commission (“SEC”), including in our Quarterly Report on Form 10-Q for the fiscal quarter ended July 31, 2026 that will be filed with the SEC following this press release. The forward-looking statements in this press release speak only as of the date on which the statements are made. We undertake no obligation to update, and expressly disclaim the obligation to update, any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.
This press release includes certain non-GAAP financial measures as defined by SEC rules. We have provided a reconciliation of those measures to the most directly comparable GAAP measures, with the exception of our Adjusted EBITDA outlook for the reasons described above.
Conference Call Information
We will hold a conference call on Wednesday, September 2, 2026 at 5:00 p.m. Eastern Time to review our fiscal 2027 second quarter financial results. To participate in our live conference call and webcast, please dial (833) 461-5787 (or (626) 884-3620 for international participants) using conference code number 285419602 or visit the “Events & Presentations” section of our Investor Relations website at ir.phreesia.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.
About Phreesia
Phreesia is a trusted leader in patient activation, giving healthcare providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled more than 180 million patient visits in 2025—1 in 6 visits across the U.S. This scale allows Phreesia to make meaningful impact across the healthcare ecosystem. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives operational efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.
|
Phreesia, Inc. Consolidated Balance Sheets (in thousands, except share and per share data) |
|||||||
|
|
July 31, 2026 |
|
January 31, 2026 |
||||
|
|
(Unaudited) |
|
|
||||
|
Assets |
|
|
|
||||
|
Current: |
|
|
|
||||
|
Cash, cash equivalents and restricted cash (including restricted cash of $— and $1,691 as of July 31, 2026 and January 31, 2026, respectively) |
$ |
72,945 |
|
|
$ |
73,830 |
|
|
Settlement assets |
|
26,746 |
|
|
|
32,999 |
|
|
Accounts receivable, net of allowance for doubtful accounts of $879 and $1,523 as of July 31, 2026 and January 31, 2026, respectively |
|
89,406 |
|
|
|
97,453 |
|
|
Cardholder receivables |
|
29,351 |
|
|
|
38,330 |
|
|
Deferred purchase price receivables |
|
14,799 |
|
|
|
18,003 |
|
|
Accrued interest and fees receivables |
|
723 |
|
|
|
840 |
|
|
Deferred contract acquisition costs |
|
394 |
|
|
|
410 |
|
|
Prepaid expenses and other current assets |
|
19,139 |
|
|
|
17,978 |
|
|
Total current assets |
|
253,503 |
|
|
|
279,843 |
|
|
Property and equipment, net of accumulated depreciation and amortization of $90,281 and $94,193 as of July 31, 2026 and January 31, 2026, respectively |
|
18,122 |
|
|
|
20,332 |
|
|
Capitalized internal-use software, net of accumulated amortization of $77,389 and $69,390 as of July 31, 2026 and January 31, 2026, respectively |
|
54,127 |
|
|
|
54,270 |
|
|
Operating lease right-of-use assets |
|
1,205 |
|
|
|
2,002 |
|
|
Deferred contract acquisition costs |
|
130 |
|
|
|
338 |
|
|
Intangible assets, net of accumulated amortization of $18,728 and $13,489 as of July 31, 2026 and January 31, 2026, respectively |
|
74,522 |
|
|
|
79,761 |
|
|
Goodwill |
|
171,468 |
|
|
|
170,064 |
|
|
Deferred tax assets |
|
990 |
|
|
|
1,593 |
|
|
Other assets (includes $1,691 and $— of long-term restricted cash as of July 31, 2026 and January 31, 2026, respectively) |
|
6,669 |
|
|
|
2,442 |
|
|
Long-term cardholder receivables |
|
59,587 |
|
|
|
47,723 |
|
|
Long-term deferred purchase price receivables |
|
6,654 |
|
|
|
5,422 |
|
|
Total Assets |
$ |
646,977 |
|
|
$ |
663,790 |
|
|
Liabilities and Stockholders’ Equity |
|
|
|
||||
|
Current: |
|
|
|
||||
|
Settlement obligations |
$ |
26,746 |
|
|
$ |
32,999 |
|
|
Current portion of debt and finance lease liabilities |
|
5,281 |
|
|
|
7,971 |
|
|
Current portion of operating lease liabilities |
|
824 |
|
|
|
1,254 |
|
|
Accounts payable |
|
12,237 |
|
|
|
11,477 |
|
|
Accrued expenses |
|
35,706 |
|
|
|
41,257 |
|
|
Due to healthcare providers |
|
29,737 |
|
|
|
38,056 |
|
|
Deferred revenue |
|
32,573 |
|
|
|
49,522 |
|
|
Other current liabilities |
|
731 |
|
|
|
705 |
|
|
Total current liabilities |
|
143,835 |
|
|
|
183,241 |
|
|
Long-term debt and finance lease liabilities |
|
61,165 |
|
|
|
92,117 |
|
|
Operating lease liabilities, non-current |
|
677 |
|
|
|
1,107 |
|
|
Long-term due to healthcare providers |
|
59,734 |
|
|
|
45,329 |
|
|
Long-term deferred revenue |
|
4,687 |
|
|
|
244 |
|
|
Long-term deferred tax liabilities |
|
4,589 |
|
|
|
4,498 |
|
|
Other long-term liabilities |
|
439 |
|
|
|
47 |
|
|
Total Liabilities |
|
275,126 |
|
|
|
326,583 |
|
|
Commitments and contingencies |
|
|
|
||||
|
Stockholders’ Equity: |
|
|
|
||||
|
Preferred stock, undesignated, $0.01 par value—20,000,000 shares authorized as of both July 31, 2026 and January 31, 2026; no shares issued or outstanding as of both July 31, 2026 and January 31, 2026 |
|
— |
|
|
|
— |
|
|
Common stock, $0.01 par value—500,000,000 shares authorized as of both July 31, 2026 and January 31, 2026; 63,516,793 and 62,020,186 shares issued as of July 31, 2026 and January 31, 2026, respectively |
|
635 |
|
|
|
620 |
|
|
Additional paid-in capital |
|
1,212,775 |
|
|
|
1,181,679 |
|
|
Accumulated deficit |
|
(794,309 |
) |
|
|
(799,190 |
) |
|
Accumulated other comprehensive loss |
|
(621 |
) |
|
|
(382 |
) |
|
Treasury stock, at cost, 1,476,215 and 1,355,169 shares as of July 31, 2026 and January 31, 2026, respectively |
|
(46,629 |
) |
|
|
(45,520 |
) |
|
Total Stockholders’ Equity |
|
371,851 |
|
|
|
337,207 |
|
|
Total Liabilities and Stockholders’ Equity |
$ |
646,977 |
|
|
$ |
663,790 |
|
|
Phreesia, Inc. Unaudited Consolidated Statements of Operations (in thousands, except share and per share data) |
|||||||||||||||
|
|
Three months ended |
|
Six months ended |
||||||||||||
|
|
|
2026 |
|
|
|
2025 |
|
|
|
2026 |
|
|
|
2025 |
|
|
Revenue: |
|
|
|
|
|
|
|
||||||||
|
Subscription and related services |
$ |
52,695 |
|
|
$ |
53,702 |
|
|
$ |
105,416 |
|
|
$ |
108,057 |
|
|
Payment solutions(1) |
|
38,489 |
|
|
|
28,392 |
|
|
|
80,430 |
|
|
|
58,317 |
|
|
Network solutions |
|
38,274 |
|
|
|
35,161 |
|
|
|
74,547 |
|
|
|
66,817 |
|
|
Total revenues |
|
129,458 |
|
|
|
117,255 |
|
|
|
260,393 |
|
|
|
233,191 |
|
|
Expenses: |
|
|
|
|
|
|
|
||||||||
|
Cost of revenue (excluding depreciation and amortization) |
|
19,271 |
|
|
|
17,398 |
|
|
|
36,930 |
|
|
|
34,035 |
|
|
Payment solutions expense(1) |
|
23,914 |
|
|
|
20,243 |
|
|
|
49,589 |
|
|
|
41,671 |
|
|
Sales and marketing |
|
24,587 |
|
|
|
25,396 |
|
|
|
48,796 |
|
|
|
51,439 |
|
|
Research and development |
|
27,571 |
|
|
|
29,274 |
|
|
|
55,899 |
|
|
|
61,103 |
|
|
General and administrative |
|
16,512 |
|
|
|
19,042 |
|
|
|
34,873 |
|
|
|
35,450 |
|
|
Depreciation |
|
3,340 |
|
|
|
3,279 |
|
|
|
6,711 |
|
|
|
6,265 |
|
|
Amortization |
|
6,655 |
|
|
|
4,130 |
|
|
|
13,238 |
|
|
|
8,022 |
|
|
Total expenses |
|
121,850 |
|
|
|
118,762 |
|
|
|
246,036 |
|
|
|
237,985 |
|
|
Operating income (loss) |
|
7,608 |
|
|
|
(1,507 |
) |
|
|
14,357 |
|
|
|
(4,794 |
) |
|
Other (expense) income, net |
|
(2,888 |
) |
|
|
336 |
|
|
|
(2,895 |
) |
|
|
674 |
|
|
Loss on extinguishment of debt |
|
— |
|
|
|
— |
|
|
|
(17 |
) |
|
|
— |
|
|
Interest expense |
|
(1,729 |
) |
|
|
(391 |
) |
|
|
(4,028 |
) |
|
|
(826 |
) |
|
Interest income |
|
248 |
|
|
|
999 |
|
|
|
545 |
|
|
|
1,204 |
|
|
Total other (expense) income, net |
|
(4,369 |
) |
|
|
944 |
|
|
|
(6,395 |
) |
|
|
1,052 |
|
|
Income (loss) before income tax expense |
|
3,239 |
|
|
|
(563 |
) |
|
|
7,962 |
|
|
|
(3,742 |
) |
|
Income tax (expense) benefit |
|
(1,321 |
) |
|
|
1,217 |
|
|
|
(3,081 |
) |
|
|
482 |
|
|
Net income (loss) |
$ |
1,918 |
|
|
$ |
654 |
|
|
$ |
4,881 |
|
|
$ |
(3,260 |
) |
|
Net income (loss) per share attributable to common stockholders: |
|
|
|
|
|
|
|
||||||||
|
Basic |
$ |
0.03 |
|
|
$ |
0.01 |
|
|
$ |
0.08 |
|
|
$ |
(0.06 |
) |
|
Diluted |
$ |
0.03 |
|
|
$ |
0.01 |
|
|
$ |
0.08 |
|
|
$ |
(0.06 |
) |
|
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
||||||||
|
Basic |
|
61,878,316 |
|
|
|
59,591,545 |
|
|
|
61,419,374 |
|
|
|
59,261,722 |
|
|
Diluted |
|
62,463,449 |
|
|
|
61,685,811 |
|
|
|
62,259,892 |
|
|
|
59,261,722 |
|
|
(1) Beginning with the fourth quarter of the fiscal year ended January 31, 2026, the revenue line previously labeled “Payment processing fees” was relabeled “Payment solutions” to reflect the expanded scope of our payments offerings following the AccessOne Acquisition, which closed on November 12, 2025. “Payment solutions” includes all revenue previously presented as “Payment processing fees” and all revenue from the operations acquired in the AccessOne Acquisition. Additionally, “Payment processing expense” was relabeled “Payment solutions expense” and includes all expenses previously presented as “Payment processing expense” and direct costs of revenue related to the operations acquired in the AccessOne Acquisition. Prior period amounts have not been reclassified, as the Company did not own the acquired operations in prior periods and the change in presentation did not affect any previously reported amounts. |
|||||||||||||||
|
Phreesia, Inc. Unaudited Consolidated Statements of Comprehensive Income (Loss) (in thousands) |
|||||||||||||||
|
|
Three months ended |
|
Six months ended |
||||||||||||
|
|
|
2026 |
|
|
|
2025 |
|
|
|
2026 |
|
|
|
2025 |
|
|
Net income (loss) |
$ |
1,918 |
|
|
$ |
654 |
|
|
$ |
4,881 |
|
|
$ |
(3,260 |
) |
|
Other comprehensive (loss) income: |
|
|
|
|
|
|
|
||||||||
|
Net change in unrealized (loss) gain on cash flow hedges |
|
(37 |
) |
|
|
(199 |
) |
|
|
(118 |
) |
|
|
208 |
|
|
Change in foreign currency translation adjustments |
|
(13 |
) |
|
|
(73 |
) |
|
|
(121 |
) |
|
|
(45 |
) |
|
Other comprehensive (loss) income |
|
(50 |
) |
|
|
(272 |
) |
|
|
(239 |
) |
|
|
163 |
|
|
Comprehensive income (loss) |
$ |
1,868 |
|
|
$ |
382 |
|
|
$ |
4,642 |
|
|
$ |
(3,097 |
) |
|
Phreesia, Inc. Unaudited Consolidated Statements of Cash Flows (in thousands) |
|||||||||||||||
|
|
Three months ended |
|
Six months ended |
||||||||||||
|
|
|
2026 |
|
|
|
2025 |
|
|
|
2026 |
|
|
|
2025 |
|
|
Operating activities: |
|
|
|
|
|
|
|
||||||||
|
Net income (loss) |
$ |
1,918 |
|
|
$ |
654 |
|
|
$ |
4,881 |
|
|
$ |
(3,260 |
) |
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
|
|
|
|
|
|
|
||||||||
|
Depreciation and amortization |
|
9,995 |
|
|
|
7,409 |
|
|
|
19,949 |
|
|
|
14,287 |
|
|
Stock-based compensation expense |
|
11,875 |
|
|
|
16,230 |
|
|
|
25,429 |
|
|
|
33,455 |
|
|
Amortization of deferred financing costs |
|
132 |
|
|
|
62 |
|
|
|
566 |
|
|
|
124 |
|
|
Loss on extinguishment of debt |
|
— |
|
|
|
— |
|
|
|
17 |
|
|
|
— |
|
|
Cost of Phreesia hardware purchased by customers |
|
245 |
|
|
|
157 |
|
|
|
433 |
|
|
|
593 |
|
|
Deferred contract acquisition costs amortization |
|
108 |
|
|
|
242 |
|
|
|
224 |
|
|
|
352 |
|
|
Non-cash operating lease expense |
|
564 |
|
|
|
218 |
|
|
|
797 |
|
|
|
433 |
|
|
Deferred taxes |
|
1,136 |
|
|
|
(1,583 |
) |
|
|
1,813 |
|
|
|
(1,498 |
) |
|
Gains and losses for fair value option |
|
2,812 |
|
|
|
— |
|
|
|
2,812 |
|
|
|
— |
|
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
||||||||
|
Accounts receivable |
|
185 |
|
|
|
(1,820 |
) |
|
|
7,916 |
|
|
|
(3,310 |
) |
|
Cash received for sale of receivables |
|
995 |
|
|
|
— |
|
|
|
8,706 |
|
|
|
— |
|
|
Accrued interest receivable |
|
(12 |
) |
|
|
— |
|
|
|
117 |
|
|
|
— |
|
|
Prepaid expenses and other assets |
|
(2,640 |
) |
|
|
(2,660 |
) |
|
|
(1,812 |
) |
|
|
(2,916 |
) |
|
Deferred contract acquisition costs |
|
— |
|
|
|
(351 |
) |
|
|
— |
|
|
|
(351 |
) |
|
Accounts payable |
|
489 |
|
|
|
2,068 |
|
|
|
648 |
|
|
|
329 |
|
|
Accrued expenses and other liabilities |
|
4,982 |
|
|
|
(1,289 |
) |
|
|
(2,003 |
) |
|
|
(2,180 |
) |
|
Payment of due to provider for receivables sold to securitization |
|
(8,480 |
) |
|
|
— |
|
|
|
(13,540 |
) |
|
|
— |
|
|
Lease liabilities |
|
(452 |
) |
|
|
(238 |
) |
|
|
(862 |
) |
|
|
(490 |
) |
|
Deferred revenue |
|
(5,524 |
) |
|
|
(4,264 |
) |
|
|
(13,841 |
) |
|
|
(5,883 |
) |
|
Net cash provided by operating activities |
|
18,328 |
|
|
|
14,835 |
|
|
|
42,250 |
|
|
|
29,685 |
|
|
Investing activities: |
|
|
|
|
|
|
|
||||||||
|
Collections of cardholder receivables held for investment and deferred purchase price |
|
26,672 |
|
|
|
— |
|
|
|
39,024 |
|
|
|
— |
|
|
Capitalized internal-use software |
|
(4,012 |
) |
|
|
(3,435 |
) |
|
|
(7,252 |
) |
|
|
(7,323 |
) |
|
Purchases of property and equipment |
|
(492 |
) |
|
|
(1,767 |
) |
|
|
(4,802 |
) |
|
|
(5,271 |
) |
|
Net cash provided by (used in) investing activities |
|
22,168 |
|
|
|
(5,202 |
) |
|
|
26,970 |
|
|
|
(12,594 |
) |
|
Financing activities: |
|
|
|
|
|
|
|
||||||||
|
Proceeds from issuance of common stock upon exercise of stock options |
|
10 |
|
|
|
114 |
|
|
|
141 |
|
|
|
242 |
|
|
Treasury stock to satisfy tax withholdings on stock compensation awards |
|
(14 |
) |
|
|
— |
|
|
|
(1,109 |
) |
|
|
— |
|
|
Proceeds from employee stock purchase plan |
|
236 |
|
|
|
575 |
|
|
|
758 |
|
|
|
1,343 |
|
|
Finance lease payments |
|
(1,188 |
) |
|
|
(2,510 |
) |
|
|
(2,868 |
) |
|
|
(3,886 |
) |
|
Principal payments on financing agreements |
|
(364 |
) |
|
|
(328 |
) |
|
|
(719 |
) |
|
|
(648 |
) |
|
Debt issuance costs and loan facility fee payments |
|
— |
|
|
|
— |
|
|
|
(2,259 |
) |
|
|
(38 |
) |
|
Debt extinguishment costs |
|
— |
|
|
|
— |
|
|
|
(42 |
) |
|
|
— |
|
|
Proceeds from debt instruments |
|
— |
|
|
|
— |
|
|
|
92,240 |
|
|
|
— |
|
|
Principal payments on debt instruments |
|
(23,500 |
) |
|
|
— |
|
|
|
(121,500 |
) |
|
|
— |
|
|
Payments due to provider for unfunded receivables |
|
(17,462 |
) |
|
|
— |
|
|
|
(33,017 |
) |
|
|
— |
|
|
Net cash used in financing activities |
|
(42,282 |
) |
|
|
(2,149 |
) |
|
|
(68,375 |
) |
|
|
(2,987 |
) |
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
25 |
|
|
|
(89 |
) |
|
|
(39 |
) |
|
|
(58 |
) |
|
Net (decrease) increase in cash, cash equivalents and restricted cash |
|
(1,761 |
) |
|
|
7,395 |
|
|
|
806 |
|
|
|
14,046 |
|
|
Cash, cash equivalents and restricted cash – beginning of period |
|
76,397 |
|
|
|
90,871 |
|
|
|
73,830 |
|
|
|
84,220 |
|
|
Cash, cash equivalents and restricted cash – end of period |
$ |
74,636 |
|
|
$ |
98,266 |
|
|
$ |
74,636 |
|
|
$ |
98,266 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Supplemental information of non-cash investing and financing information: |
|
|
|
|
|
|
|
||||||||
|
Non-cash activity related to credit card receivables and deferred purchase price |
$ |
20,992 |
|
|
$ |
— |
|
|
$ |
48,709 |
|
|
$ |
— |
|
|
Exchange of right of use asset for property and equipment |
$ |
— |
|
|
$ |
— |
|
|
$ |
57 |
|
|
$ |
— |
|
|
Purchase of property and equipment and capitalized software included in accounts payable and accrued liabilities |
$ |
2,140 |
|
|
$ |
2,461 |
|
|
$ |
2,140 |
|
|
$ |
2,461 |
|
|
Capitalized stock-based compensation |
$ |
238 |
|
|
$ |
320 |
|
|
$ |
580 |
|
|
$ |
652 |
|
|
Issuance of stock to settle liabilities for stock-based compensation |
$ |
919 |
|
|
$ |
1,346 |
|
|
$ |
8,972 |
|
|
$ |
7,854 |
|
|
Cash paid for: |
|
|
|
|
|
|
|
||||||||
|
Interest |
$ |
703 |
|
|
$ |
330 |
|
|
$ |
4,551 |
|
|
$ |
654 |
|
|
Income taxes |
$ |
2,884 |
|
|
$ |
763 |
|
|
$ |
4,065 |
|
|
$ |
1,314 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Reconciliation of cash, cash equivalents and restricted cash shown in statements of cash flows |
|
|
|
|
|
|
|
||||||||
|
Cash, cash equivalents and restricted cash per balance sheets |
$ |
72,945 |
|
|
$ |
98,266 |
|
|
$ |
72,945 |
|
|
$ |
98,266 |
|
|
Restricted cash included in other long-term assets |
|
1,691 |
|
|
|
— |
|
|
|
1,691 |
|
|
|
— |
|
|
Total cash, cash equivalents and restricted cash shown in statements of cash flows |
$ |
74,636 |
|
|
$ |
98,266 |
|
|
$ |
74,636 |
|
|
$ |
98,266 |
|
Contacts
Investor Relations Contact:
Balaji Gandhi
Phreesia, Inc.
[email protected]
(929) 506-4950
Media Contact:
Nicole Gist
Phreesia, Inc.
[email protected]
(407) 760-6274
